Proclaiming baby milk powder can "stimulate your height potential", and well -known brands have been fined

According to the official website of the Shanghai Market Supervision Bureau, recently, the Abbott Trading (Shanghai) Co., Ltd. stated that its non -health food baby milk powder can "improve growth and development" and "reduce constipation", etc. during the live broadcast, Fined 200,000. On September 2nd, a reporter from Nandu · Bay Finance called Abbott Trading (Shanghai) Co., Ltd., and as of press time, he did not receive a reply.

Screenshot of the official website of Shanghai Market Supervision Bureau

Punishment:

Non -health food baby milk powder can "improve growth and development", "laxative", etc.

Abbott was fined 200,000

According to the administrative penalty decision, after investigation, Abbott Trading (Shanghai) Co., Ltd. launched the "Super Flash CP" live broadcast in the live broadcast room of the JD.com platform "Abbott Jingdong Selfic Campaign Store" on July 21, 2021. In order to increase product sales, increase product awareness, live broadcast promotion activities for infant formula milk powder. During the live broadcast event, the anchor of the product "Abbott Jingzi organic children's formula modulation milk powder 4 section 4" was introduced during the publicity that the product "a potential that can stimulate this height"; Proclaiming the product "a situation of constipation such as constipation and reducing diarrhea." The two products mentioned above are not health foods, but its "improvement and development" and "laxative" claimed in the advertisement belong to the function of health food.

The Market Supervision and Administration Bureau of Shanghai Pudong New Area believes that the company's live broadcast of non -health food infants and young children claims to have the function of "improving growth and development" and "laxative", and violates the "Implementation Regulations of the Food Safety Law of the People's Republic of China" No. 1 No. 1 Article 38 Paragraph 1 "For other foods other than health foods, they must not claim to have health care functions." And Article 11, paragraph 11 of the "Advertising Law of the People's Republic of China": 11) The provisions of laws and administrative regulations prohibited. "The provisions constituted illegal acts that claim to have health care functions in the advertisement, and fined Abbott Trade (Shanghai) Co., Ltd. 200,000 Essence

Screenshot of administrative punishment decision

Condor::

He was fined about 9.09 million yuan for a section of infant with milk powder to check that Xianglanin was fined about 9.09 million yuan

A reporter from Nandu · Bay Finance noticed that this was not the first time that Abbott had been punished for publishing illegal advertisements. On June 22, 2021, the company was fined 848,000 by the Shanghai Market Supervision and Administration Bureau for issuing illegal advertisements. The punishment information shows that after investigation, it is recommended and introduced the Abbott scanning glucose monitoring system (belonging to the third category of medical devices). The main content contains the name and image of the Real Madrid player Nacho Fernandez, as well as the video or picture Weibo advertisement of the product introduction of the Abbott scanning glucose monitoring system and attach the "Abbott scanned glucose monitoring system, sweep, easily test sugar" and so on. Advertising slogan. The Shanghai Market Supervision and Administration Bureau believes that the above -mentioned advertising behavior violates Article 16, paragraph 1, paragraph 4, paragraph 4, paragraph 3 of the "Advertising Law of the People's Republic of China". 4) Advertising with advertising spokespersons for recommendations and proofs "and" recommending medical devices for individuals should be significantly indicated, "Please read and use 'to purchase and use'" in the guidance of medical staff. "

Screenshots of the official website of the National Enterprise Credit Information Publicity System

Earlier, the quality of infant milk powder of Abbott had also had problems. According to Nandu's previous report, on May 6, 2021, Abbott Trading (Shanghai) Co., Ltd. was fined 9.0931 million yuan by the Shanghai Market Supervision Bureau. The punishment information shows that the company produced by the African Platinum Younemei Baby Formula Milk Powder was detected by section of 0-9 June. The requirements for use of additives. "Requirements. In response to this, Abbott China responded to Nandu reporters that the product batch number containing Xianglanin was found to be 18042NT, but "the extreme micro -microfinancecin detected in this batch of products is harmless to infants and young children." Essence And involving the same batch of products that have been detected in the excellent standard, Abbott stated that all the recycling of the batch of products reserved in the market has completed. "If you have this batch of products in the hands of consumers, please contact us in time company".

Screenshots of the official website of the National Enterprise Credit Information Publicity System

On February 20 this year, the General Administration of Customs issued an announcement, reminding consumers that they did not purchase through any channels and immediately suspended the edible infant formula of the relevant infant milk powder under the US Abbott. According to the announcement, the products involved include a variety of milk powder from Abbott. Products and a baby nutritional supplement. According to the official website of the FDA, consumer complaints have been received a few days ago, and all four cases related to these complaints are hospitalized and treated. One of them may die due to infection.

Screenshot of the official website of the General Administration of Customs

Public information shows that the second quarter of the 2022 performance of Abbott shows that quarterly revenue was US $ 11.257 billion, an increase of 10.1%year -on -year.The company's net profit was US $ 2.018 billion, an increase of 69.7%year -on -year.According to business, the diagnostic business revenue was US $ 4.322 billion, an increase of 33.1%year -on -year, and revenue related to the test of the new crown virus was 2.3 billion US dollars.Medical equipment sales were US $ 3.757 billion, an increase of 2.5%year -on -year.Nutrition business revenue was 1.953 billion US dollars, a year -on -year decrease of 7.4%.Pharmaceutical business sales were US $ 1.223 billion, an increase of 3.7%year -on -year.Southern Metropolis Daily (NDDAILY) and N video reports Nandu Appraisal Evaluation Laboratory

- END -